General Hospital Leskovac

Leskovac 16000

1 studies enrolling now · 5 studies all time

What they study most

Acute Ischemic Stroke, Crohn's Disease, Inflammatory Bowel Diseases, Multiple Sclerosis, Relapsing-Remitting, Myocardial Infarction, Ulcerative Colitis

Studies at this site

• A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease — Recruiting now
• A Phase 2b, Randomized, Double-blind Study of Redasemtide (S-005151) in Adult Participants With Acute Ischemic Stroke — Completed
• Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis — Running, not enrolling
• EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction) — Completed
• Phase 2 Dose-finding IMU-838 for Ulcerative Colitis — Stopped early